Advanced Solid Tumors
Showing NaN - NaN of 76
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
San Antonio, Texas
- +1 more
Sep 8, 2023
Advanced Solid Tumors Trial in Worldwide (BGB-30813, Tislelizumab)
Not yet recruiting
- Advanced Solid Tumors
-
Hackensack, New Jersey
- +10 more
Jun 6, 2023
Advanced Solid Tumors, NSCLC Trial in Israel, United States (BAY2862789)
Not yet recruiting
- Advanced Solid Tumors
- Non-small Cell Lung Cancer
-
Detroit, Michigan
- +5 more
May 5, 2023
Advanced Solid Tumors Trial in Switzerland, United States (Debio 0123)
Recruiting
- Advanced Solid Tumors
- Debio 0123
-
Grand Rapids, Michigan
- +3 more
Jan 27, 2023
Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)
Recruiting
- Advanced Solid Tumors
- +5 more
- PF-07265028
- Sasanlimab
-
Scottsdale, Arizona
- +7 more
Jan 23, 2023
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)
Completed
- Advanced Malignancy
- +5 more
- AMG 820
-
Philadelphia, Pennsylvania
- +2 more
Jan 18, 2023
Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- ASP1948
- +2 more
-
New Haven, Connecticut
- +41 more
Jan 10, 2023
Advanced Solid Tumors Trial in Worldwide (ASP1951, pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
-
Tucson, Arizona
- +31 more
Jan 10, 2023
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
Boston, Massachusetts
- +9 more
Dec 22, 2022
Advanced Solid Tumors Trial in Canada, Singapore, United States (BAY3375968, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumors
-
Chicago, Illinois
- +4 more
Sep 9, 2022
Advanced Solid Tumors Trial in Worldwide (Quavonlimab, Pembrolizumab, Pembrolizumab/Quavonlimab)
Active, not recruiting
- Advanced Solid Tumors
- Quavonlimab
- +2 more
-
Gilbert, Arizona
- +52 more
Aug 18, 2022
Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies Trial in
Recruiting
- Advanced Solid Tumors
- +2 more
- INCA00186
- +2 more
-
Los Angeles, California
- +31 more
Jul 20, 2022
NSCLC, Advanced Solid Tumors, Gastroesophageal Adenocarcinoma Trial in Worldwide (ABBV-400)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
-
Santa Monica, California
- +25 more
Jun 27, 2022
Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)
Terminated
- Advanced Solid Tumors
-
Los Angeles, California
- +29 more
May 21, 2022